Preveceutical Medical Inc C.PREV

Alternate Symbol(s): PRVCF

PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is a cannabinoid-based nose-to-brain delivery system that provides relief to a range of indications from pain, inflammation, seizures, and neurological disorders. Its Dual Gene Therapy for curative and prevention therapies for diabetes and obesity. Its Nature Identical peptides for treatment of various ailments. Its BSV peptide program targets cancer progression. Its nonaddictive analgesic peptides as a replacement to the highly addictive analgesics such as morphine, fentanyl and oxycodone and a therapeutic product for treating athletes who suffer from concussions (mild traumatic brain injury).

CSE:PREV - Post by User

Preveceutical Medical Inc

Bullboard Posts

Comment by Ravenelon Nov 27, 2018 8:56pm

69 Views

Post# 29030890

RE:80 Mil was in Shares and Warrants

I told Deanna from IR that they should press release today, she said she would discuss it with the CEO and their lawyers but as it stood at that time, they were advised by the BCSC and their lawyers not to until the investigation of Bridgemark was completed.

Bullboard Posts

Changing Europe’s dependency on HREE from China